Shelton Capital Management Pacific Biosciences Of California, Inc. Transaction History

Shelton Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $188,247 - $410,503	-47,900 Reduced 14.52%	282,100 $1.64 Million
Q2 2022 Aug 11, 2022	BUY	$4.02 - $10.43 $924,599 - $2.4 Million	230,000 Added 230.0%	330,000 $1.46 Million
Q1 2022 May 12, 2022	SELL	$8.43 - $20.9 $295,050 - $731,500	-35,000 Reduced 25.93%	100,000 $910,000
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $1.09 Million - $1.54 Million	44,000 Added 48.35%	135,000 $3.45 Million
Q2 2021 Aug 12, 2021	BUY	$22.3 - $36.02 $646,700 - $1.04 Million	29,000 Added 46.77%	91,000 $3.18 Million
Q1 2021 May 14, 2021	BUY	$26.38 - $51.15 $1.13 Million - $2.2 Million	43,000 Added 226.32%	62,000 $2.07 Million
Q4 2020 Feb 16, 2021	BUY	$10.5 - $28.5 $199,500 - $541,500	19,000 New	19,000 $493,000

255

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $450M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.